- About UNAIDS
- Our work
- Targets and commitments
- 2011 Political Declaration: Targets and elimination commitments
- Reducing sexual transmission
- Preventing HIV among drug users
- Eliminating new HIV infections among children
- 15 million accessing treatment
- Avoiding TB deaths
- Closing the resource gap
- Eliminating gender inequalities
- Eliminating stigma and discrimination
- Eliminating travel restrictions
- Strengthening HIV integration
- 2011 Political Declaration: Targets and elimination commitments
More Office of the Chief Scientific Adviser to UNAIDS feature stories
- On International Women’s Day, UNAIDS, IAS and 14 partners launch new agenda to improve scientific research for women and children
- As the world marks International Women’s Day, there is growing concern that women and children are bearing the brunt of the AIDS epidemic. To turn the tide, UNAIDS, the International AIDS Society (IAS) and 14 other leading public and private sector organizations have teamed up to release a new scientific research agenda.
- During Winter Olympics, UNAIDS calls on Canada to ensure G8 delivers on universal access
- A global summit on HIV was hosted by LifeSciences British Columbia, the BC Centre of Excellence in HIV/AIDS, and the University of British Columbia (UBC) on 26 February against the backdrop of the 2010 Olympic Games. Endorsed by the International AIDS Society, the event "The Impact of Science & Innovation in the Evolving Global Health Paradigm: HIV and AIDS - A Challenge of Olympic Proportion" brought together world leaders in HIV research, health, innovation and policy to share latest and compelling perspectives on the challenges being faced under a shifting global health paradigm.
- Eastern Europe and Central Asia HIV conference for joint efforts towards Universal Access
- The 3rd HIV/AIDS Conference in Eastern Europe and Central Asia opened in Moscow today with a ceremony attended by senior representatives of Russian Duma, Russian Ministry of Foreign Affairs, Russian Academy of Sciences and the US Ambassador to the Russian Federation. Participants and organizers hope it will invigorate the regional response to the AIDS epidemic.
- Scientists come together for the AIDS Vaccine Conference 2009
- The yearly AIDS Vaccine Conference opened in Paris today. High on the agenda are discussions on the progress made in vaccine development and implications of trail results for the future.
- OPINION: HIV vaccine—a public good to right a global wrong
- The promise of a vaccine against HIV has got one step closer. Results from the largest vaccine trial ever conducted show a modest but encouraging 31% efficacy in preventing new HIV infections in Thailand. This has vindicated thousands of scientists and volunteers who have been hoping that a safe and highly effective HIV vaccine is possible.
- Largest ever HIV vaccine trial results very encouraging
- Geneva, 24 September 2009 – The World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) are optimistic about the results, announced today, of the largest ever HIV vaccine clinical trial held to date.
- Resources for regular lab tests could be used for HIV treatment
- Having 12 children and a very old mother to support, Vincent, middle-aged Ugandan single father living with HIV, knows that his death would spell disaster for the whole family. “If I had died, where would these people go?” said Vincent perched on a stool with his legs outstretched.
- Evidence shows new drug combination dramatically reduces mother-to child transmission of HIV during breastfeeding
- According to a new study led by WHO, if HIV-positive pregnant women are given a combination of antiretroviral drugs from late in pregnancy until six months into breastfeeding, rather than a short course of drugs that ends at delivery, their babies are over 40% less likely to become infected with HIV.
- Young researcher from Kenya recognized at 5th IAS Conference
- This year’s recipient is Dr Linnet N. Masese, Kenya, for her abstract, A prospective cohort study of the effect of antiretroviral therapy on sexual risk behaviour in a high-risk cohort of Kenyan women. It was selected by a review committee from eligible abstracts submitted to and accepted for presentation at IAS 2009.
- Better HIV diagnosis in mothers and infants to avoid death from TB vaccine
- Bacille Calmette-Guérin, or BCG, is one of the most widely given vaccines globally and is safe in people with healthy immune systems. WHO recently published further research on the finding that this standard tuberculosis vaccine has a higher risk of causing death in babies living with HIV.
- Collaboration between TB Alliance and Tibotec offers hope of accelerated tuberculosis drug development
- In response to the urgent need to accelerate the discovery and development of new drugs to fight tuberculosis (TB), a landmark collaboration between the Global Alliance for TB Drug Development (TB Alliance), a non-profit, product development partnership, and Tibotec Inc., (Tibotec), a global pharmaceutical company, was announced at the Pacific Health Summit.
- Consultation held on definition and measurement of concurrent sexual partnerships
- It has long been suggested that concurrent sexual partnerships are one component responsible for creating sexual contact networks conducive to the rapid spread of HIV. Recently the idea has gained prominence and momentum, with national HIV programmes beginning to plan prevention campaigns targeted at reducing concurrent partnerships. However, in both the scientific and programmatic communities, research and discussion about concurrent partnerships and their role in the spread of HIV have been impeded by lack of clarity about the definition and appropriate indicators of concurrency.
- Advocating for HIV trials that work for women
- Women and girls, who constitute half of all people living with HIV, are often underrepresented in biomedical HIV trials. One year ago today a two-day meeting concluded which marked the beginning of the Women and HIV Trials initiative. This new forum opened a dialogue to challenge research norms underpinning the relative invisibility of women in clinical trial design, implementation, and reporting. The event was hosted by four partners, UNAIDS, GCWA, ICRW and Tibotec.
- BBC News reports bone marrow 'cures HIV patient'
- According to a BBC report on 13 November 2008, 'Doctors in Germany say a patient appears to have been cured of HIV by a bone marrow transplant from a donor who had a genetic resistance to the virus.'
- Focus on new HIV prevention technologies
- HIV prevention was the focus of a meeting organized by the UK Department for International Development on 4 November in London. Politicians, scientists, international organizations and civil society gathered to evaluate current HIV prevention strategies and assess the steps forward. UNAIDS Deputy Executive Director Michel Sidibe also took part in the meeting.
- STI Online: Supplement on UNAIDS estimation methods and tools
- Ahead of the publication of the 2008 Global Report, Sexually Transmitted Infections, a peer review journal for health professionals and researchers in sexual health has published a supplement giving a description and underlying data for UNAIDS estimation methods and tools, as well as analyses on a range of epidemiological issues including quantifying HIV burden in emergencies, the quality of global serosurveillance and a method for estimating averted infections.
- Microbicides 2008 concludes in India
- Microbicides 2008 conference ended on a positive note when it closed 27 February in New Delhi with delegates hopeful that the lessons shared and learned from recent trials will help deliver results soon.
- Microbicides: challenges to development and distribution (Part 2)
- In the second of a two part series looking at microbicides, we will be exploring new developments in microbicide research including basic science, clinical trials and social science issues as well as discussion on behaviour, community engagement and advocacy.
- Microbicides: why are they significant? (Part 1)
- Ahead of next week’s biannual international microbicides conference Microbicides 2008 running 24 – 27 February in New Delhi we take an in-depth look at microbicides. In part 1 of this 2-part series we look at why they are considered significant in the response to HIV. In part 2 the challenges to the development of this preventative technology will be explored.
- Overview of this year’s Conference on Retroviruses and Opportunistic Infections (CROI)
- The annual Conference on Retroviruses and Opportunistic Infections (CROI) began in 1994 as a small meeting of scientists studying HIV and clinicians treating people with HIV. It is now one of the most important annual HIV gatherings and provides a forum for basic scientists, clinical investigators, and global health researchers to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and the diseases they produce.
Press centre
- 21 May 2013
-
UNAIDS reports more than 7 million people now on HIV treatment across Africa––with nearly 1 million added in the last year—while new HIV infections and deaths from AIDS continue to fall . More
- 21 May 2013
-
UNAIDS saddened by death of human rights activist Shivananda Khan. More